クリニック紹介

発表一覧

• Twist-1 Is a PPARδ-Inducible, Negative-Feedback Regulator of PGC-1α in Brown Fat Metabolism(cell)
• Inducible Nitric-oxide Synthase and NO Donor Induce Insulin Receptor Substrate-1 Degradation in Skeletal Muscle Cells* - Journal of Biological Chemistry
• A Role for iNOS in Fasting Hyperglycemia and Impaired Insulin Signaling in the Liver of Obese Diabetic Mice
• R3hdml regulates satellite cell proliferation and differentiation
• Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma
• CXCL12-CXCR4 pathway activates brown adipocytes and induces insulin resistance in CXCR4-deficient mice under high-fat diet
• Bone Marrow-derived Vascular Cells in Response to Injury
• METABOLIC IMPROVEMENT AND ABDOMINAL FAT REDISTRIBUTION IN WERNER SYNDROME BY PIOGLITAZONE
• Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor sitagliptin compared with α‐glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS‐2): a multicenter, randomized, open‐label, non‐inferiority trial
• Atorvastatin ameliorates podocyte injury in patients with type 2 diabetes complicated with dyslipidemia
• Japanese diabetic patients with Werner syndrome exhibit high incidence of cancer
• Incidence and Characteristics of Metabolic Disorders and Vascular Complications in Individuals with Werner Syndrome in Japan
• Sitagliptin Successfully Ameliorates Glycemic Control in Werner Syndrome With Diabetes
• Primary lung cancer associated with Werner syndrome - Ohnishi - 2010 - Geriatrics & Gerontology International
• Halofuginone prevents extracellular matrix deposition in diabetic nephropathy
• CCN3 Inhibits Neointimal Hyperplasia Through Modulation of Smooth Muscle Cell Growth and Migration
• The roles of transforming growth factor-β and Smad3 signaling in adipocyte differentiation and obesity
• An Angiotensin II Type 1 Receptor Blocker Prevents Renal Injury via Inhibition of the Notch Pathway in Ins2 Akita Diabetic Mice
• A case of Werner syndrome without metabolic abnormality: Implications for the early pathophysiology
• Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy
• The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: An open label pilot study
• Influence of C‐peptide on early glomerular changes in diabetic mice
• Clinical Outcome and Mechanism of Soft Tissue Calcification in Werner Syndrome
• 健康食品，新五浄心の摂取により偽性アルドステロン症を発症した高齢者の1例
• Identification and characterization of high glucose and glucosamine responsive element in the rat osteopontin promoter
• High Glucose-Induced Upregulation of Osteopontin Is Mediated via Rho/Rho Kinase Pathway in Cultured Rat Aortic Smooth Muscle Cells
• Targeted Disruption of TGF-β–Smad3 Signaling Leads to Enhanced Neointimal Hyperplasia With Diminished Matrix Deposition in Response to Vascular Injury
• A report of a case with Werner's syndrome suffering from end-stage renal failure
• Twist-1 Is a PPARδ-Inducible, Negative-Feedback Regulator of PGC-1α in Brown Fat Metabolism(sciencedirect)
• 癌転移促進因子Twist1の新規エネルギー代謝制御機構の解析
• 肥満症（第2版）
• 網膜症と腎症の進行程度に顕著な差異を認めた高齢者2型糖尿病の1例
• 肥満と脂肪代謝: Current therapy. (カレントテラピー)
• 2011年度交付者/成果報告書
• 肥満が主体のメタボリックシンドロームの薬物療法 新規抗肥満薬の開発動向
• 生活習慣病とAnti-aging Science
• 運動継続の達成方法にせまる
• Q&Aでわかる 肥満と糖尿病 Vol.10/No.5
• 3 薬物療法：2.抗肥満作用のある各種薬剤
• 高齢者の慢性疾患に伴う低栄養・サルコペニアの評価に関する研究
• 新しい脂質代謝改善薬の可能性を探る